Cardiac failure congestive and Pulmonary toxicity

Summary:

Pulmonary toxicity is found among people with Cardiac failure congestive, especially for people who are male, 60+ old.

The study analyzes which people have Pulmonary toxicity with Cardiac failure congestive. It is created by eHealthMe based on reports of 18 people who have Cardiac failure congestive from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Cardiac failure congestive?

Cardiac failure congestive is found to be associated with 2,158 drugs and 2,144 conditions by eHealthMe. Check the latest studies of Cardiac failure congestive.

What is Pulmonary toxicity?

Pulmonary toxicity (side effects on the lungs) is found to be associated with 375 drugs and 466 conditions by eHealthMe. Check the latest studies of Pulmonary toxicity.



On Jul, 19, 2026

18 people who have Cardiac Failure Congestive and Pulmonary Toxicity are studied.

Would you have Pulmonary toxicity when you have Cardiac failure congestive?

Gender of people who have Cardiac Failure Congestive and experienced Pulmonary Toxicity *:

  • female: 29.41 %
  • male: 70.59 %

Age of people who have Cardiac Failure Congestive and experienced Pulmonary Toxicity *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 6.67 %
  • 50-59: 6.67 %
  • 60+: 86.67 %

Common co-existing conditions for these people *:

  1. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 13 people, 72.22%
  2. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 16.67%
  3. Glaucoma (increased fluid pressure in the eye with vision loss): 2 people, 11.11%
  4. Arrhythmias (irregular heartbeat): 2 people, 11.11%
  5. High Blood Pressure: 2 people, 11.11%
  6. Coronary Heart Disease (narrowing or blockage of the coronary arteries): 2 people, 11.11%
  7. Dyslipidaemia (abnormal amount of lipids): 1 person, 5.56%
  8. Blindness: 1 person, 5.56%
  9. Cardiac Amyloidosis (protein deposition in heart): 1 person, 5.56%
  10. Cardioversion: 1 person, 5.56%

Common drugs taken by these people *:

  1. Amiodarone Hydrochloride: 6 people, 33.33%
  2. Isordil: 1 person, 5.56%
  3. Amlodipine: 1 person, 5.56%
  4. Baby Aspirin: 1 person, 5.56%
  5. Cordarone: 1 person, 5.56%
  6. Crestor: 1 person, 5.56%
  7. Dexamethasone: 1 person, 5.56%
  8. Imbruvica: 1 person, 5.56%
  9. Zantac: 1 person, 5.56%
  10. Xarelto: 1 person, 5.56%

Common symptoms for these people *:

  1. Pneumonia: 5 people, 27.78%
  2. Pleural Effusion (water on the lungs): 3 people, 16.67%
  3. Lung Consolidation (a condition whereby the lung tissues solidify because of the accumulation of solid and liquid material in the air spaces): 3 people, 16.67%
  4. Acute Respiratory Failure: 3 people, 16.67%
  5. Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 2 people, 11.11%
  6. Pulmonary Mass: 2 people, 11.11%
  7. Dyspnea (difficult or laboured breathing): 2 people, 11.11%
  8. Chest Pain: 1 person, 5.56%
  9. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 5.56%
  10. Confusional State: 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Pulmonary toxicity?

- Check whether Pulmonary toxicity is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Pulmonary toxicity:

All the conditions that are associated with Pulmonary toxicity:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Pulmonary toxicity and Cardiac failure congestive, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: